Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


       2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Ondansetron Base Taj Pharmaceuticals Ltd.

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  
Ondansetron Base Manufacturers in India Suppliers Ondansetron Base Exporters Distributors Ondansetron Base api active pharmaceuticals ingredients Ondansetron Base manufacturers Side Effects bulk drugs raw material Ondansetron Base companies Side Effects Importers Ondansetron Base Ondansetron Base Exporters Ondansetron Base exporters FDA Ondansetron Base DMF Symptoms Generic Taj Pharmaceuticals Ltd. active pharmaceutical ingredients suppliers pharmaceutical Ondansetron Base manufacturing pharmaceutical drugs pharmaceutical intermediates Ondansetron Base pharmaceutical chemicals pharmaceutical raw materials Ondansetron Base active pharmaceutical ingredients Ondansetron Base committee active pharmaceutical ingredients manufacturer Ondansetron Base Active Pharmaceutical Ingredients manufacturer Ondansetron Base exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Ondansetron Base, Ondansetron Base manufacturer India, Ondansetron Base product, Ondansetron Base products, Api preparation, Certificate of Analysis API manufacturer product, Ondansetron Base anti ulcer product, Certificate of Origin COA Ondansetron Base COS Ondansetron Base, pharmaceutical generic, pharmaceutical drug, medical, Ondansetron Base pharma healthcare, pharma patents, contract MSDS manufacturing Trader Ondansetron Base pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Ondansetron Base expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Ondansetron Base DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Ondansetron Base ingredients, api, HIV Ondansetron Base, tablets, capsules, syrup & protein Ondansetron Base powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Ondansetron Base gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Ondansetron Base WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

Ondansetron Base Img.










 

 

 






 

 

 

HOME >> API >> API List 3 >> Ondansetron Base >> Drug Description

Ondansetron Base CAS number 116002-70-1

DRUG DESCRIPTION
Ondansetron Base CAS number 116002-70-1

Ondansetron Base is a white to off-white powder that is soluble in water and normal saline.Each 1 mL of aqueous solution in the 2-mL single-dose vial contains 2 mg of ondansetron as the hydrochloride dihydrate; 9.0 mg of sodium chloride, USP; and 0.5 mg of citric acid monohydrate, USP and 0.25 mg of sodium citrate dihydrate, USP as buffers in Water for Injection, USP. Each 1 mL of aqueous solution in the 20-mL multidose vial contains 2 mg of ondansetron as the hydrochloride dihydrate; 8.3 mg of sodium chloride, USP; 0.5 mg of citric acid monohydrate, USP and 0.25 mg of sodium citrate dihydrate, USP as buffers; and 1.2 mg of methylparaben, NF and 0.15 mg of propylparaben, NF as preservatives in Water for Injection, USP.

This medication is used to prevent nausea and vomiting caused by cancer chemotherapy or after surgery. It works by blocking the hormone (serotonin) that causes vomiting.

Ondansetron is in a class of medications called 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.

Ondansetron comes as a tablet, a rapidly disintegrating (dissolving) tablet, and an oral solution to take by mouth. The first dose of ondansetron is usually taken 30 minutes before the start of chemotherapy, 1 to 2 hours before the start of radiation therapy, or 1 hour before surgery. Additional doses are sometimes taken one to three times a day during chemotherapy or radiation therapy and for 1 to 2 days after the end of treatment. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take ondansetron exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

If you are taking the rapidly disintegrating tablet, remove the tablet from the package just before you take your dose. To open the package, do not try to push the tablet through the foil backing of the blister Instead, use dry hands to peel back the foil backing. Gently remove the tablet and immediately place the tablet on the top of your tongue. The tablet will dissolve in a few seconds and can be swallowed with saliva.

Information Associated with Product:
DRUG DESCRIPTION >>
DOSAGE
SIDE EFFECTS
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo
 

Ondansetron Base

Api Manufacturer,Export,Supplies,Manufacturing in India

Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

 

    Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited  products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.